Cosmos Health Inc. COSM
Nasdaq · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 2010-05-19 · LEI
Cosmos Health Inc. statistics & valuation
Market cap$10.7M
P / S0.2×
P / B0.6×
Net margin-29.3%
Return on equity-103.9%
FCF margin-13.0%
Net debt$3.1M
Enterprise value USD$13.7M
Earnings yield EBIT/EV-121.5%
Return on capital-61.4%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 12.1% | 7.9% | 8.1% | 11.8% | 14.8% | 14.5% | 9.2% | 6.5% | 6.5% | 8.9% |
| Operating margin | -25.6% | -28.6% | -40.9% | -14.8% | -8.1% | 4.9% | -0.6% | -3.3% | -16.2% | -3.0% |
| Net margin | -29.3% | -29.7% | -34.7% | -27.5% | -14.2% | 1.5% | -8.3% | -24.4% | -20.7% | -8.9% |
| FCF margin | -13.0% | -14.9% | -31.8% | -29.7% | -13.7% | -21.0% | — | -5.6% | -29.4% | -31.7% |
| Return on assets | -29.2% | -29.8% | -28.1% | -20.3% | -16.1% | 1.9% | -13.8% | -43.8% | -58.2% | -19.3% |
| Return on equity | -103.9% | -66.0% | -51.4% | -35.2% | -181.8% | -19.7% | 51.1% | 273.1% | 205.1% | 34.3% |
| Debt / equity | 0.20× | 0.17× | 0.13× | 0.13× | 4.09× | -2.59× | -0.00× | -0.04× | — | — |
| Current ratio | 1.00 | 0.99 | 1.51 | 2.59 | 1.33 | 1.19 | 0.75 | 0.82 | 0.69 | 0.54 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.